[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
    "url": "https://finnhub.io/api/news?id=3fccd8a3ea31da93867ed121960162fe745c46ffee72bd13d37a110b721064c5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758645300,
      "headline": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
      "id": 136868805,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market",
      "url": "https://finnhub.io/api/news?id=3fccd8a3ea31da93867ed121960162fe745c46ffee72bd13d37a110b721064c5"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific’s Valuation: Assessing New Launches and Upgraded Outlook",
    "summary": "Thermo Fisher Scientific has been grabbing headlines lately with a flurry of new product launches, including the Olink Target 48 Neurodegeneration panel, the Gibco Efficient-Pro Medium (+) Insulin, and the Hypulse Surface Analysis System. These launches go beyond minor upgrades, representing bold moves into key areas such as neurodegenerative disease research, biopharma manufacturing, and advanced surface analysis. Paired with news that the company has raised its revenue and earnings outlook,...",
    "url": "https://finnhub.io/api/news?id=4ce383061caf5ce4825b2ed3a08ea9cc89d15782399cf8e35788bd1e4b5dba16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758625950,
      "headline": "Thermo Fisher Scientific’s Valuation: Assessing New Launches and Upgraded Outlook",
      "id": 136850757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific has been grabbing headlines lately with a flurry of new product launches, including the Olink Target 48 Neurodegeneration panel, the Gibco Efficient-Pro Medium (+) Insulin, and the Hypulse Surface Analysis System. These launches go beyond minor upgrades, representing bold moves into key areas such as neurodegenerative disease research, biopharma manufacturing, and advanced surface analysis. Paired with news that the company has raised its revenue and earnings outlook,...",
      "url": "https://finnhub.io/api/news?id=4ce383061caf5ce4825b2ed3a08ea9cc89d15782399cf8e35788bd1e4b5dba16"
    }
  }
]